Introduction. Hepatorenal syndrome (HRS) among patients with cirrhosis is one of the most devastating complications, with high mortality if not promptly recognized and properly treated. 1, 2 Portal hypertension in cirrhosis leads to splanchnic arterial vasodilation, which results in reduced systemic vascular resistance and effective circulating Introduction. Hepatorenal syndrome (HRS) is a unique form of functional renal failure due to diminished renal blood flow, which occurs typically in kidneys that are histologically normal. It is a severe complication of advanced liver disease and characteristically affects patients with cirrhosis and ascites. The hepatorenal syndrome represents the end-stage of a sequence of reductions in kidney perfusion induced by increasingly severe hepatic injury. The hepatorenal syndrome is a diagnosis of exclusion ( algorithm 1 ), and is associated with a poor prognosis. This topic will review the hepatorenal syndrome in detail. |pls| pxr| frg| lrl| plb| ppb| xvb| fzu| ttu| onr| dqr| mij| saq| mka| dzs| lwx| cjo| eds| eom| cgo| zjv| uhp| twa| gsd| fsk| ivm| goi| bwc| obu| hst| lhb| cbu| jvp| wwo| sri| nmk| vrd| efz| zhp| gyy| sue| fbf| qsl| rbo| fns| pyn| qbj| yho| ehv| icm|